怀孕期间使用抗抑郁药与儿童自闭症谱系障碍之间的关系:一项基于日本索赔数据的回顾性队列研究。

Maternal health, neonatology and perinatology Pub Date : 2019-01-10 eCollection Date: 2019-01-01 DOI:10.1186/s40748-018-0096-y
Madoka Yamamoto-Sasaki, Satomi Yoshida, Masato Takeuchi, Sachiko Tanaka-Mizuno, Yusuke Ogawa, Toshiaki A Furukawa, Koji Kawakami
{"title":"怀孕期间使用抗抑郁药与儿童自闭症谱系障碍之间的关系:一项基于日本索赔数据的回顾性队列研究。","authors":"Madoka Yamamoto-Sasaki,&nbsp;Satomi Yoshida,&nbsp;Masato Takeuchi,&nbsp;Sachiko Tanaka-Mizuno,&nbsp;Yusuke Ogawa,&nbsp;Toshiaki A Furukawa,&nbsp;Koji Kawakami","doi":"10.1186/s40748-018-0096-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Studies using data from Western countries have raised concerns that treating pregnant women with antidepressants may increase the risk of autism spectrum disorders (ASDs) in their offspring. However, to date, the studies are inconclusive. We therefore examined the association between antidepressant use and ASD using claims data collected in Japan.</p><p><strong>Methods: </strong>This retrospective cohort study was based on claims data from mothers and their children from January 2005 to July 2014, obtained from the Japan Medical Data Center. The information from mothers and children was linked using the family identification code. Information on antidepressant prescriptions during pregnancy was extracted from the database. To collect information on ASD, children for whom data were available 24 months or more after birth were followed up from birth through July 2014 or up until their withdrawal from the database. To ensure appropriate diagnosis of ASD, mother-child pairs where the children's data did not cover the 24 months after birth or pairs where children had a diagnosis of ASD within only 23 months after birth were excluded from the study cohort. We used logistic regression analyses to evaluate the association between antidepressant use during pregnancy and the children's ASD diagnosis. All statistical analyses were performed using IBM SPSS (Statistical Package for the Social Sciences) Statistics ver. 21.0.</p><p><strong>Results: </strong>Of the 53,864 eligible mother-child pairs, 26,925 met the study criteria. Crude analysis showed that the ASD prevalence in children was significantly higher with any antidepressant use than with non-use (odds ratio [OR], 2.32; 95% confidence interval [CI], 1.08, 4.95). However, when the analysis was adjusted for the confounding effect of maternal depression during pregnancy, statistical significance was lost (OR, 0.76; CI, 0.27, 2.18).</p><p><strong>Conclusions: </strong>After adjustment for confounders, we found no significant association between antidepressant use during pregnancy and ASD in children in Japan. This result provides additional evidence to support the idea that antidepressant use during pregnancy itself is not associated with an increase in ASD in children. In addition, this represents the first evidence based on Asian data.</p>","PeriodicalId":74120,"journal":{"name":"Maternal health, neonatology and perinatology","volume":"5 ","pages":"1"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40748-018-0096-y","citationCount":"10","resultStr":"{\"title\":\"Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data.\",\"authors\":\"Madoka Yamamoto-Sasaki,&nbsp;Satomi Yoshida,&nbsp;Masato Takeuchi,&nbsp;Sachiko Tanaka-Mizuno,&nbsp;Yusuke Ogawa,&nbsp;Toshiaki A Furukawa,&nbsp;Koji Kawakami\",\"doi\":\"10.1186/s40748-018-0096-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Studies using data from Western countries have raised concerns that treating pregnant women with antidepressants may increase the risk of autism spectrum disorders (ASDs) in their offspring. However, to date, the studies are inconclusive. We therefore examined the association between antidepressant use and ASD using claims data collected in Japan.</p><p><strong>Methods: </strong>This retrospective cohort study was based on claims data from mothers and their children from January 2005 to July 2014, obtained from the Japan Medical Data Center. The information from mothers and children was linked using the family identification code. Information on antidepressant prescriptions during pregnancy was extracted from the database. To collect information on ASD, children for whom data were available 24 months or more after birth were followed up from birth through July 2014 or up until their withdrawal from the database. To ensure appropriate diagnosis of ASD, mother-child pairs where the children's data did not cover the 24 months after birth or pairs where children had a diagnosis of ASD within only 23 months after birth were excluded from the study cohort. We used logistic regression analyses to evaluate the association between antidepressant use during pregnancy and the children's ASD diagnosis. All statistical analyses were performed using IBM SPSS (Statistical Package for the Social Sciences) Statistics ver. 21.0.</p><p><strong>Results: </strong>Of the 53,864 eligible mother-child pairs, 26,925 met the study criteria. Crude analysis showed that the ASD prevalence in children was significantly higher with any antidepressant use than with non-use (odds ratio [OR], 2.32; 95% confidence interval [CI], 1.08, 4.95). However, when the analysis was adjusted for the confounding effect of maternal depression during pregnancy, statistical significance was lost (OR, 0.76; CI, 0.27, 2.18).</p><p><strong>Conclusions: </strong>After adjustment for confounders, we found no significant association between antidepressant use during pregnancy and ASD in children in Japan. This result provides additional evidence to support the idea that antidepressant use during pregnancy itself is not associated with an increase in ASD in children. In addition, this represents the first evidence based on Asian data.</p>\",\"PeriodicalId\":74120,\"journal\":{\"name\":\"Maternal health, neonatology and perinatology\",\"volume\":\"5 \",\"pages\":\"1\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/s40748-018-0096-y\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Maternal health, neonatology and perinatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s40748-018-0096-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maternal health, neonatology and perinatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40748-018-0096-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

摘要

背景:使用西方国家数据的研究引起了人们的关注,即用抗抑郁药治疗孕妇可能会增加其后代患自闭症谱系障碍(asd)的风险。然而,到目前为止,这些研究还没有定论。因此,我们使用在日本收集的索赔数据来研究抗抑郁药使用与ASD之间的关系。方法:本回顾性队列研究基于2005年1月至2014年7月来自日本医疗数据中心的母亲及其子女的索赔数据。来自母亲和孩子的信息通过家庭识别码联系在一起。从数据库中提取孕期抗抑郁药处方信息。为了收集有关ASD的信息,对出生后24个月或更长时间有数据的儿童进行了随访,从出生到2014年7月,或者直到他们从数据库中退出。为了确保对ASD的正确诊断,将儿童出生后24个月内的数据或出生后仅23个月内诊断为ASD的母子对排除在研究队列之外。我们使用逻辑回归分析来评估怀孕期间使用抗抑郁药与儿童ASD诊断之间的关系。所有统计分析均使用IBM SPSS (statistical Package for the Social Sciences)统计软件进行。21.0.结果:在53864对符合条件的母婴中,26925对符合研究标准。粗略分析显示,使用任何抗抑郁药物的儿童ASD患病率均显著高于未使用抗抑郁药物的儿童(优势比[OR], 2.32;95%可信区间[CI], 1.08, 4.95)。然而,当对孕妇孕期抑郁的混杂效应进行校正时,没有统计学意义(OR, 0.76;Ci, 0.27, 2.18)。结论:在调整混杂因素后,我们发现日本怀孕期间使用抗抑郁药与儿童ASD之间没有显著关联。这一结果为怀孕期间使用抗抑郁药本身与儿童ASD增加无关的观点提供了额外的证据。此外,这是基于亚洲数据的第一个证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data.

Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data.

Background: Studies using data from Western countries have raised concerns that treating pregnant women with antidepressants may increase the risk of autism spectrum disorders (ASDs) in their offspring. However, to date, the studies are inconclusive. We therefore examined the association between antidepressant use and ASD using claims data collected in Japan.

Methods: This retrospective cohort study was based on claims data from mothers and their children from January 2005 to July 2014, obtained from the Japan Medical Data Center. The information from mothers and children was linked using the family identification code. Information on antidepressant prescriptions during pregnancy was extracted from the database. To collect information on ASD, children for whom data were available 24 months or more after birth were followed up from birth through July 2014 or up until their withdrawal from the database. To ensure appropriate diagnosis of ASD, mother-child pairs where the children's data did not cover the 24 months after birth or pairs where children had a diagnosis of ASD within only 23 months after birth were excluded from the study cohort. We used logistic regression analyses to evaluate the association between antidepressant use during pregnancy and the children's ASD diagnosis. All statistical analyses were performed using IBM SPSS (Statistical Package for the Social Sciences) Statistics ver. 21.0.

Results: Of the 53,864 eligible mother-child pairs, 26,925 met the study criteria. Crude analysis showed that the ASD prevalence in children was significantly higher with any antidepressant use than with non-use (odds ratio [OR], 2.32; 95% confidence interval [CI], 1.08, 4.95). However, when the analysis was adjusted for the confounding effect of maternal depression during pregnancy, statistical significance was lost (OR, 0.76; CI, 0.27, 2.18).

Conclusions: After adjustment for confounders, we found no significant association between antidepressant use during pregnancy and ASD in children in Japan. This result provides additional evidence to support the idea that antidepressant use during pregnancy itself is not associated with an increase in ASD in children. In addition, this represents the first evidence based on Asian data.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信